1
Unitaid
Strategy and Investment Portfolio
October 2018
2
Agenda
2
Strategy 2017 - 2021
Investment Portfolio
2016-06-30-UNITAID strategy -IAS Durban-v7-UPDATED.pptx 3
Maximize the effectiveness
of the global health response
better health products
catalyzing equitable access
Our mission
by to
4
Upstream
Systems
Innovation & Availability
Devices
Supply & Delivery
Medicines
Quality
Demand & Adoption
Affordability
Unitaid connects the upstream to the downstream
HIV/AIDS Tuberculosis Malaria
Downstream
PDPs BMGF Industry Academia Others Grand
Challenges
…
4
5
Global Goals
Challenges
Opportunities
Areas for interventions
Calls for proposals
Projects
Disease narratives
Disease Narrative – Malaria
Disease Narrative – Tuberculosis
Disease Narrative – HIV
Disease Narrative – Hepatitis C
in the context of co-infection with
HIV
Areas for intervention
HIV E.g. Scale-up of PrEP
TB E.g. Latent TB
Malaria E.g. IPTp
HCV E.g. Simple, rapid diagnosis of HCV
Projects
Unitaid translates global goals into concrete projects
5
6
Challenges are prioritized with a systematic analysis
6
UNITAID's landscapes
Global strategies
Ongoing partner consultation
Civil society Technical partners
Funding partners
Governments
Private sector Implementers
Partners' strategies & reports
Technology availability
Health product access 1
2
3
Critical gap
4
Public health impact
Challenge A Challenge B Challenge C Challenge D
Challenge A Challenge C
Unitaid plays a role at 3 critical moments
7
Objectives Innovation Scalability Access
Moment 2 Product is adopted
Moment 3 Product is scaled-up
Moment 1 Product is available
Pro
du
ct c
ove
rage
Maximize the effectiveness of the
global health response...
... by catalyzing equitable access...
... to better health products
The cascade of care
Test
Prevent
Treat Monitor
9
Current portfolio Grants in development New AFI
Advanced HIV disease
Reduce AIDS-related mortality to
500,000 deaths by 2020
Children Adults
New grants- PrEP
Test
Prevent
Treat Monitor
Viral Load ~ US$173m
STAR Self-
testing ~
US$ 80m EID
~US$
100m
Cro
ss
-cu
tting
ATLAS -
Self testing
WH
O E
na
ble
r, WH
O P
Q,
MP
P, IT
PC
HIV and co-infection portfolio
ARV portfolio
~US$ 118m
PrEP~ US$26m
HCV diagnosis HCV treatment
Unitaid’s investments in TB
Test
Prevent
Treat
Scale-up better TB treatment for children
Enable preventive TB treatment in high-risk
groups
Better, shorter treatment for MDR-TB
Monitor (adherence)
MDR TB
Grants in development/calls
Unitaid’s investments in TB
Test
Prevent
Treat
TB-SPEED (Univ Bordeaux)
IMPAACT4TB (Aurum)
endTB (Partners in Health)
Adherence (monitor)
CAP TB (EGPAF)
WHO Enabler Other CC: MPP & PQ
Unitaid’s investments in Malaria
Current portfolio Grants in development/calls New AFI
Refer
Treat
Treat
Cro
ss-cuttin
g
MM
V su
pp
ly, WH
O e
nab
ler, W
HO
PQ
RTS,s (WHO)
Test Prevent
Vector control
Catalytic LLIN (IVCC)
TIPTOP
(JHPIEGO)
NGenIRS (IVCC)
Fever Dx
New grants
RAS (CHAI) Signs of
Severe disease
Thank you